While the downregulation of intracellular p62 by SARS-CoV-2 might promote viral replication by preventing antiviral immunity in the host, an increase in p62 levels might be anti-inflammatory triggering autophagy-dependent blockade of the infection process (47). Here, SQSTM1 is linked to infection.